Relative bioavailability of olsalazine from tablets and capsules: A drug targeted for local effect in the colon
- 1 April 1991
- journal article
- clinical trial
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 12 (3) , 233-246
- https://doi.org/10.1002/bdd.2510120308
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Acetylation of 5-aminosalicylic acid by isolated human colonic epithelial cellsClinical Science, 1990
- The pharmacokinetics of olsalazine sodium in healthy volunteers after a single i.v. dose and after oral doses with and without foodEuropean Journal of Clinical Pharmacology, 1988
- Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract.Gut, 1987
- Azodisal sodium in the treatment of ulcerative colitisGastroenterology, 1986
- Disposition of disodium azodisalicylate in healthy subjectsGastroenterology, 1985
- Absorption and Excretion of a Single 1-g Dose of Azodisal Sodium in Subjects with IleostomyScandinavian Journal of Gastroenterology, 1983
- Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.Gut, 1982
- TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMASThe Lancet, 1981
- Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.Gut, 1980
- Absorption, metabolism, and excretion of salicylazosulfapyridine in manClinical Pharmacology & Therapeutics, 1972